Munich, Georgia

Peter Kastner

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.2

ph-index = 1


Location History:

  • Staffelsee, DE (2022)
  • Murnau am Staffelsee, DE (2023 - 2024)

Company Filing History:


Years Active: 2022-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Contributions of Peter Kastner

Introduction

Peter Kastner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in predicting stroke and atrial fibrillation risks. With a total of 3 patents, his work has the potential to impact patient care and treatment outcomes.

Latest Patents

Kastner's latest patents include innovative methods for predicting the risk of stroke and the recurrence of atrial fibrillation. One of his patents focuses on the use of circulating Angiopoietin-2 (Ang-2) and insulin-like growth factor-binding protein 7 (IGFBP7) to enhance the accuracy of clinical stroke risk scores. This method involves determining the levels of these biomarkers in a subject's sample to assess stroke risk effectively. Another patent addresses the prediction of atrial fibrillation recurrence by measuring Ang-2 levels, providing a diagnostic tool for healthcare professionals.

Career Highlights

Peter Kastner is currently employed at Roche Diagnostics Operations, Inc., where he continues to develop groundbreaking diagnostic methods. His work is characterized by a commitment to improving patient outcomes through innovative research and technology.

Collaborations

Kastner collaborates with esteemed colleagues, including Ursula-Henrike Wienhues-Thelen and Johann Karl, to advance his research and patent applications. Their combined expertise contributes to the development of effective diagnostic tools in the medical field.

Conclusion

Peter Kastner's contributions to medical diagnostics through his patents demonstrate his dedication to innovation and improving healthcare. His work in predicting stroke and atrial fibrillation risks showcases the importance of research in enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…